通鼎互聯(002491.SZ):控股股東質押2200萬股及解除質押2000萬股
格隆匯12月11日丨通鼎互聯(002491.SZ)公佈,公司於2019年12月11日接到控股股東通鼎集團有限公司(“通鼎集團”)有關辦理股權質押及解除質押的通知,此次質押數量2200萬股,解除質押2000萬股。
未來半年內到期的質押股份累計數量為17287.71萬股,佔其所持股份比例32.59%,佔公司總股本比例13.70%,對應融資餘額8.17億元,還款來源為自籌資金;未來一年內到期的質押股份累計數量為22327.71萬股,佔其所持股份比例42.09%,佔公司總股本比例17.70%,對應融資餘額11.27億元,還款來源為自籌資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.